|Table of Contents|

The prognostic model of TGF-β pathway related genes in ependymoma constructed by bioinformatics

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 06
Page:
1032-1037
Research Field:
Publishing date:

Info

Title:
The prognostic model of TGF-β pathway related genes in ependymoma constructed by bioinformatics
Author(s):
FAN Yandong1ZHU Manli2DENG Guoqi1WANG Jiaming3LUO Kun1
1.Neurosurgery Department,the Second Affiliated Hospital of Xinjiang Medical University,Xinjiang Urumqi 830054,China;2.Central Laboratory,Xinjiang Medical University,Xinjiang Urumqi 830054,China;3.Neurosurgery Department,the First Affiliated Hospital of Xinjiang Medical University,Xinjiang Urumqi 830054,China.
Keywords:
TGF-β signaling pathwayependymomabioinformaticsprediction model
PACS:
R739.4
DOI:
10.3969/j.issn.1672-4992.2024.06.008
Abstract:
Objective:To establish a prognostic model of TGF-β signaling pathway related genes in ependymoma based on bioinformatics.Methods:Unsupervised clustering algorithm was used to distinguish the different molecular subtypes of ependymoma.Gene set variation analysis (GSVA) was used to calculate TGF-β signal pathway-related scores in different ependymoma subtypes.The survival rates of patients with different ependymoma subtypes were calculated by Kaplan-Meier analysis (KM).Linear models for microarray data (limma) were used to analyze the differential genes among different ependymoma subtypes.Least absolute shrinkage and selection operator (LASSO) and COX proportional hazards model were used to construct a prognostic model of TGF-β signaling pathway related genes in ependymoma.Receiver operating characteristic curve (ROC) was used to evaluate the performance of prognostic prediction model.Pearson correlation analysis was used to investigate the correlation of important genes.qRT-PCR and Western blot were used to investigate the expression of important genes in ependymoma tissues.Results:The unsupervised clustering algorithm showed that there were two different subtypes in ependymoma.GSVA and KM analysis showed that TGF-β signaling pathway scores and prognosis were significantly different in different subtypes of ependymomas.The results of gene differential expression analysis showed that TGF-β pathway related gene expression was significantly different in different subtypes of ependymomas.LASSO showed that BMP4,FBN1,CDC20 and TGFB1 were the important genes of prognosis prediction model.ROC analysis results showed that TGF-β signaling pathway related gene model had high predictive performance.The results of Pearson correlation analysis showed that BMP4,FBN1,CDC20,TGFB1 were significantly correlated with the downstream genes of TGF-β signaling pathway.qRT-PCR and western blot showed that the expressions of BMP4,FBN1,CDC20 and TGFB1 were significantly up-regulated in ependymal tissues.Conclusion:The prognosis prediction model based on TGF-β pathway related genes BMP4,FBN1,CDC20 and TGFB1 can effectively predict the survival of patients with ependymoma.

References:

[1] SALEH AH,SAMUEL N,JURASCHKA K,et al.The biology of ependymomas and emerging novel therapies [J].Nature Reviews Cancer,2022,22(4):208-222.
[2] SCHAFF LR,MELLINGHOFF IK.Glioblastoma and other primary brain malignancies in adults:a review [J].Jama,2023,329(7):574-587.
[3] PASKEH MDA,MEHRABI A,GHOLAMI MH,et al.EZH2 as a new therapeutic target in brain tumors:Molecular landscape,therapeutic targeting and future prospects [J].Biomedicine & Pharmacotherapy,2022,146:112532.
[4] AUBIN RG,TROISI EC,MONTELONGO J,et al.Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma [J].Nature Communications,2022,13(1):3936.
[5] LIAO C,AN J,YI S,et al.FUT8 and protein core fucosylation in tumours:from diagnosis to treatment [J].Journal of Cancer,2021,12(13):4109-4120.
[6] PENG D,FU M,WANG M,et al.Targeting TGF-β signal transduction for fibrosis and cancer therapy [J].Molecular Cancer,2022,21(1):104.
[7] ZENG C,HE R,DAI Y,et al.Identification of TGF-β signaling-related molecular patterns,construction of a prognostic model,and prediction of immunotherapy response in gastric cancer [J].Frontiers in Pharmacology,2022,13:1069204.
[8] RIDDER DA,URBANSKY LL,WITZEL HR,et al.Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma,mediates tumor progression,and predicts unfavorable outcome [J].Cancers,2022,14(2):430.
[9] TAURIELLO DVF,SANCHO E,BATLLE E.Overcoming TGFβ-mediated immune evasion in cancer [J].Nature Reviews Cancer,2022,22(1):25-44.
[10] LI S,LIU M,DO MH,et al.Cancer immunotherapy via targeted TGF-β signalling blockade in T(H) cells [J].Nature,2020,587(7832):121-125.
[11] WU MZ,YUAN YC,HUANG BY,et al.Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis [J].Signal Transduction and Targeted Therapy,2021,6(1):395.
[12]刘晨,隋红.TGF-β信号通路介导胃癌EMT的研究进展[J].现代肿瘤医学,2020,28(03):517-520. LIU Chen,SUI Hong.Research progress on TGF-β signaling pathway in mediating EMT of gastric cancer[J].Modern Oncology,2020,28(03):517-520.
[13]王春刚,陈山,王志峰,等.长链非编码RNA LIMT调控TGF-β信号通路对肺癌细胞增殖与凋亡的影响[J].现代肿瘤医学,2020,28(18):3108-3113. WANG Chungang,CHEN Shan,WANG Zhifeng,et al.Effect of long non-coding RNA LIMT regulating TGF-β signaling pathway on proliferation and apoptosis of lung cancer cells[J].Modern Oncology,2020,28(18):3108-3113.
[14] JANG E,SHIN MK,KIM H,et al.Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells [J].Experimental & Molecular Medicine,2023,55(5):974-986.
[15] OLBRECHT S,BUSSCHAERT P,QIAN J,et al.High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing:specific cell subtypes influence survival and determine molecular subtype classification [J].Genome Medicine,2021,13(1):111.
[16] ZUO H,YANG D,WAN Y.Fam20C regulates bone resorption and breast cancer bone metastasis through osteopontin and BMP4 [J].Cancer Research,2021,81(20):5242-5254.
[17] FERNANDEZ-SEVILLA LM,VALENCIA J,ORTIZ-SANCHEZ P,et al.High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes [J].Blood,2022,139(22):3303-3313.
[18] WANG Z,CHEN W,ZUO L,et al.The Fibrillin-1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells [J].Cancer Communications (London,England),2022,42(3):245-265.
[19] WANG X,SHI X,LU H,et al.Succinylation inhibits the enzymatic hydrolysis of the extracellular matrix protein fibrillin 1 and promotes gastric cancer progression [J].Advanced Science (Weinheim,Baden-Wurttemberg,Germany),2022,9(27):e2200546.
[20] JEONG SM,BUI QT,KWAK M,et al.Targeting Cdc20 for cancer therapy [J].Biochimica et Biophysica Acta Reviews on Cancer,2022,1877(6):188824.
[21] CHEN OJ,CASTELLSAGUE E,MOUSTAFA-KAMAL M,et al.Germline missense variants in CDC20 result in aberrant mitotic progression and familial cancer [J].Cancer Research,2022,82(19):3499-3515.
[22] GABITOVA-CORNELL L,SURUMBAYEVA A,PERI S,et al.Cholesterol pathway inhibition induces TGF-β signaling to promote basal differentiation in pancreatic cancer [J].Cancer Cell,2020,38(4):567-583.e11.
[23] XU J,SHAO T,SONG M,et al.MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer [J].Molecular Cancer,2020,19(1):51.

Memo

Memo:
省部共建中亚高发病成因与防治国家重点实验室开放课题项目(编号:SKL-HIDCA-2022-NKX2)
Last Update: 1900-01-01